Contribution: Industrial Research Assistance Program – Contributions to Firms
Elarex Inc.
$74,700.00
Design and Testing of Assays to Enable Rapid Prototyping
FY 2021-22 · 2021-09-01
Summary
Develop a rapid assay platform to support rapid testing and screening of a vast array of formulations to support our goal of increasing the stability of antibody based therapeutics.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Burlington|Burlington, Ontario, Canada
Recipient Type
For-profit organization
Business Number
756228474
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-09-01 | 2021-22 | $74,700.00 |
| 1 | 2021-09-01 | 2021-22 | $74,700.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 31 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 31 jours.
Agreement End Date
2022-03-31
Agreement Number
975372
Agreement Start Date
2021-09-01
Agreement Title
Design and Testing of Assays to Enable Rapid Prototyping
Agreement Title (French)
Conception et test des essais pour permettre un prototypage rapide
Agreement Type
Contribution
Agreement Value
$74,700.00
Amendment Date
2022-01-13
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Develop a rapid assay platform to support rapid testing and screening of a vast array of formulations to support our goal of increasing the stability of antibody based therapeutics.
Description (French)
Mettre au point une plateforme de test rapide permettant de tester et de cribler rapidement un large éventail de formulations, et ce, afin de soutenir notre objectif d'accroître la stabilité des produits thérapeutiques à base d'anticorps.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Burlington
Federal Riding (French)
Burlington
Federal Riding Number
35015
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
756228474
Recipient City
Burlington|Burlington
Recipient Country
CA
Recipient Legal Name
Elarex Inc.
Recipient Postal Code
L7L 4X5
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2021-2022-Q2-975372
